BioNTech Will Apply in U.S. For Emergency Use of Covid Vaccine
Media Call: Pfizer-BioNTech COVID-19 Vaccine Actions – 1/3/2022Подробнее
Vaccines and Related Biological Products Advisory Committee – 10/26/2021Подробнее
The Watchman News - Pfizer-BioNTech Covid Vaccine Given Emergency Authorization By FDA For Kids 5-11Подробнее
Covid vaccine: USA's first full approval for Pfizer-BioNTech jab amid Delta surgeПодробнее
FDA rejecte emergency use authorization for covaxin|US FDA denies Bharat biotech's covaxinПодробнее
No emergency use, US FDA asks Bharat Biotech to obtain full approvalПодробнее
Why US drug regulator rejects emergency use of Bharat Biotech’s Covaxin | Brijendar GuptaПодробнее
Pfizer-BioNTech vaccine for 5-11 y/o, no application yet in PH — DOHПодробнее
US authorises Pfizer-BioNTech COVID-19 shots for children aged 5-11Подробнее
Pfizer-BioNTech COVID-19 vaccine receives full approval by U.S. FDAПодробнее
FDA rejects Bharat Biotech COVAXIN emergency use/ US rejects Indian VaccineПодробнее
WHO approves Sinovac Biotech’s coronavirus vaccine for emergency useПодробнее
Bharat Biotech covaxin rejected approval by US FDA for emergency use | UPSC | SSCПодробнее
Pfizer-BioNTech files for U.S. approval of COVID-19 vaccineПодробнее
US FDA Denies Bharat Biotech’s Covaxin Emergency Use Approval | USA FDA rejects Covaxin | In EnglishПодробнее
Pfizer, BioNTech begin process seeking full FDA approval for COVID vaccineПодробнее
Bharat Biotech's Covaxin rejected for emergency use authorization by U.S FDAПодробнее
No Emergency Use Approval For Bharat Biotech's Covaxin In U.S, FDA Seeks More Info & DataПодробнее
US FDA rejects emergency use authorisation for Bharat Biotech's Covaxin - TV9Подробнее
CARPHA COVID-19 Health Round: COVID-19 Vaccines Recommendations – AstraZeneca, Pfizer-BioNTechПодробнее
